Clinical Observation of Bifid Triple Viable Capsule in the Treatment of Ulcerative Colitis / 中国药房
China Pharmacy
;
(12): 5095-5096, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-501341
ABSTRACT
OBJECTIVE:
To observe the efficacy and safety of Bifid triple viable capsule in the treatment of ulcerative colitis (UC).METHODS:
94 patients with UC were randomly divided into control group and research group. Control groups was given nutrition support,light diet and 5-amino salicylic acid and other conventional treatment;research group was additionally given 420 mg Bifid triple viable capsule,3 times aday. Treatment course for both group was 8 weeks. The clinical efficacy,and serum D-lac-tic acid,diamine oxidase(DAO)levels before and after treatment,and incidence of adverse reactions in 2 groups were observed.RESULTS:
The total effective rate in research group was significantly higher than control group,the difference was statistically sig-nificant(P0.05).CONCLUSIONS:
Based on the conventional treatment,both the efficacy and safety of Bifid triple viable capsule are good in the treatment of UC.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
China Pharmacy
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS